Cochlear Investor Relations Material
Latest events
H1 2025
Cochlear
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cochlear Limited
Access all reports
Cochlear Limited is an Australia-based medical device company specializing in implantable hearing solutions. The company designs, manufactures, and distributes cochlear implants, bone conduction systems, and acoustic implants, providing solutions for individuals with moderate to profound hearing loss. Cochlear also offers a range of services and accessories to support patients and healthcare professionals throughout the hearing restoration process.
Key slides for Cochlear Limited
H2 2024
Cochlear Limited
H1 2025
Cochlear Limited
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
COH
Country
🇦🇺 Australia